J. David Enloe Jr - Feb 15, 2022 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Role
Chief Executive Officer, Director
Signature
Ryan D Lake, attorney-in-fact
Stock symbol
SCTL
Transactions as of
Feb 15, 2022
Transactions value $
$1,011
Form type
4
Date filed
2/17/2022, 04:23 PM
Previous filing
Jan 24, 2022
Next filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Purchase $1.01K +571 +0.11% $1.77 524K Feb 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.